AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2018
Jan 23, 2018
29864_dirs_2018-01-23_bf0f3f36-9420-474b-b2f8-3a5d004be12c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2018-01-19
Reporting Person: Sachdev Amit (EVP, CRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-19 | Common Stock | M | 18672 | $77.31 | Acquired | 57835 | Direct |
| 2018-01-19 | Common Stock | M | 13750 | $83.36 | Acquired | 71585 | Direct |
| 2018-01-19 | Common Stock | S | 18410 | $157.67 | Disposed | 53175 | Direct |
| 2018-01-19 | Common Stock | S | 13312 | $158.59 | Disposed | 39863 | Direct |
| 2018-01-19 | Common Stock | S | 700 | $159.35 | Disposed | 39163 | Direct |
| 2018-01-22 | Common Stock | M | 13750 | $83.36 | Acquired | 52913 | Direct |
| 2018-01-22 | Common Stock | S | 13750 | $160.00 | Disposed | 39163 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-19 | Stock Option (Right to Buy) | $77.31 | M | 18672 | Disposed | 2024-02-04 | Common Stock (18672) | Direct |
| 2018-01-19 | Stock Option (Right to Buy) | $83.36 | M | 13750 | Disposed | 2023-07-29 | Common Stock (13750) | Direct |
| 2018-01-22 | Stock Option (Right to Buy) | $83.36 | M | 13750 | Disposed | 2023-07-29 | Common Stock (13750) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 882 | Indirect |
| Common Stock | 12215 | Indirect |
Footnotes
F1: Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
F2: Open market sales reported on this line occurred at a weighted average price of $157.67 (range $157.18 to $158.17).
F3: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4: Open market sales reported on this line occurred at a weighted average price of $158.59 (range $158.20 to $159.10).
F5: Open market sales reported on this line occurred at a weighted average price of $159.35 (range $159.27 to $159.45).
F6: Reflects a change in the form of ownership resulting from transfers of shares between a trust and Mr. Sachdev.
F7: The option vests in 16 quarterly installments from 2/5/2014.
F8: Fully vested.